Epistatus® and other licensed products
Acute prolonged seizures (Epilepsy)
ApprovedActive
Key Facts
About Veriton Pharma
Veriton Pharma is a specialised pharmaceutical company, acquired by SERB Pharmaceuticals in 2020, that develops and commercialises tailored therapies for unmet medical needs, with a core focus on CNS disorders like epilepsy and rare paediatric conditions. It operates a hybrid portfolio of licensed prescription products and a broad range of unlicensed 'specials', supported by a trusted supply chain and direct NHS engagement. The company benefits from SERB's global infrastructure and antidote portfolio, positioning it as a key player in niche therapeutic areas with a strong service-oriented model for hospitals and prescribers worldwide.
View full company profile